Page 306 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Fatty Liver Disease: Clinical (Cont.)

YI P1067 ASSOCIATIONS BETWEEN ANTIDIABETIC AND STATIN
THERAPY AND LIVER HISTOLOGY IN PATIENTS WITH
TYPE 2 DIABETES AND NON-ALCOHOLIC FATTY LIVER
DISEASE
Fabio Nascimbeni*, Judith Aron-Wisniewsky, Raluca Pais, Joan Tordjman,
Frederic Charlotte, Pierre Bedossa, Thierry Poynard, Karine Clement,
Vlad Ratziu, Italy, France

YI P1068 METFORMIN TREATMENT AMELIORATES LIVER INJURY
INDICATING FATTY LIVER IN POLYCYSTIC OVARY
SYNDROME
Susanne Tan, Nils Vollmar, Jan-Peter Sowa*, Sven Benson,
Lars P. Bechmann, Guido Gerken, Dagmar Führer, Ali Canbay, Germany

YI P1069 THE ASSOCIATION BETWEEN FATTY LIVER STATUS
CHANGE AND INCIDENCE OF DIABETES MELLITUS IN
JAPAN
Kazumasa Nagai*, Toru Tsuboya, Hajime Yamazaki, Akiko Tomonari,
Kunihiko Tsuji, Hiroyuki Maguchi, Japan

ePOSTERS YI P1070 THE MARKER OF MACROPHAGE ACTIVATION SOLUBLE
CD163 IS ASSOCIATED WITH LIVER HISTOLOGY IN
CHILDREN WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Konstantin Kazankov*, Holger J. Møller, Anna Alisi, Rita De Vito,
Hendrik Vilstrup, Valerio Nobili, Henning Grønbæk, Denmark

YI P1071 THE ASSOCIATION BETWEEN SERUM LEVELS OF
URIC ACID AND ALANINE AMINOTRANSFERASE IN A
POPULATION-BASED COHORT
Liane Rabinowich*, Ofir Ben-Assuli, Manfred Green, Alex Goldstein,
Avi Magid, Varda Shalev, Oren Shibolet, Gabi Chodick, Shira Zelber-
Sagi, Israel

YI P1072 THE INTERACTION BETWEEN VISCERAL ADIPOSE AND
HEPATIC TISSUE AFFECTS LIVER INJURY IN NAFL AND
NASH PATIENTS
Martin Schlattjan*, Jan-Peter Sowa, Svenja Sydor, Guido Gerken,
Lars P. Bechmann, Ali Canbay, Germany

YI P1073 INTERLEUKIN 15 IN NONALCOHOLIC FATTY LIVER
DISEASE AND OBESITY
Olena Kurinna*, Galyna Fadieienko, Oleg Babak, Tatyana Solomentseva,
Ksenya Syntyk, Ukraine

306 The International Liver Congress™ 2015 • ILC Programme